NM_213649.2:c.538-199T>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_213649.2(SFXN4):​c.538-199T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 151,840 control chromosomes in the GnomAD database, including 7,562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7562 hom., cov: 31)

Consequence

SFXN4
NM_213649.2 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.347

Publications

13 publications found
Variant links:
Genes affected
SFXN4 (HGNC:16088): (sideroflexin 4) This gene encodes a member of the sideroflexin family. The encoded protein is a transmembrane protein of the inner mitochondrial membrane, and is required for mitochondrial respiratory homeostasis and erythropoiesis. Mutations in this gene are associated with mitochondriopathy and macrocytic anemia. Alternatively spliced transcript variants have been found in this gene. [provided by RefSeq, Jan 2014]
SFXN4 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-119156955-A-G is Benign according to our data. Variant chr10-119156955-A-G is described in ClinVar as Benign. ClinVar VariationId is 667486.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.375 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFXN4NM_213649.2 linkc.538-199T>C intron_variant Intron 9 of 13 ENST00000355697.7 NP_998814.1 Q6P4A7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFXN4ENST00000355697.7 linkc.538-199T>C intron_variant Intron 9 of 13 1 NM_213649.2 ENSP00000347924.2 Q6P4A7-1

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45406
AN:
151722
Hom.:
7566
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.163
Gnomad AMI
AF:
0.405
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.304
Gnomad EAS
AF:
0.170
Gnomad SAS
AF:
0.391
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.308
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.299
AC:
45401
AN:
151840
Hom.:
7562
Cov.:
31
AF XY:
0.304
AC XY:
22547
AN XY:
74154
show subpopulations
African (AFR)
AF:
0.163
AC:
6754
AN:
41414
American (AMR)
AF:
0.285
AC:
4345
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.304
AC:
1055
AN:
3468
East Asian (EAS)
AF:
0.169
AC:
877
AN:
5178
South Asian (SAS)
AF:
0.390
AC:
1879
AN:
4816
European-Finnish (FIN)
AF:
0.458
AC:
4808
AN:
10492
Middle Eastern (MID)
AF:
0.245
AC:
72
AN:
294
European-Non Finnish (NFE)
AF:
0.362
AC:
24590
AN:
67938
Other (OTH)
AF:
0.309
AC:
652
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1520
3041
4561
6082
7602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.336
Hom.:
37813
Bravo
AF:
0.274
Asia WGS
AF:
0.304
AC:
1055
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.9
DANN
Benign
0.50
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2297696; hg19: chr10-120916467; API